A lipid tumor suppressor
Nature Chemical Biology
2012년8월27일
The discovery that the lipid C18-ceramide is a tumor suppressor provides insight into the autophagy paradox, as reported online in Nature Chemical Biology this week. This work may open new avenues for the development of anti-cancer therapies.
There are many ways that a cell can die, including through a process termed autophagy. Paradoxically under different conditions, autophagy can promote either cell survival or cell death. The events that control these disparate cellular outcomes have, until now, remained elusive.
Besim Ogretmen and colleagues report that C18-ceramide, a lipid and a putative tumor suppressor, interacts with a protein called LC3B-II and tethers it to the membrane of a cellular organelle, known as the mitochondrion. They also show that persistent localization of LC3B-II in the mitochondrial membrane leads to mitochondrial dysfunction and ultimately cell death. In addition they noted that overproduction of C18-ceramide was sufficient to slow the growth of xenografted tumors in mice.
Collectively, these data provide evidence that C18-ceramide has tumor suppressor activity and opens a new avenue for the identification of anti-cancer agents.
doi: 10.1038/nchembio.1059
리서치 하이라이트
-
2월18일
Nature Energy Focus issue: How extreme weather events disrupt energy systemsNature Energy
-
1월28일
Materials science: Increased nuclear waste storage corrosion at material interfacesNature Materials
-
1월9일
Ecology: Reassessing impacts of ocean acidification on fish behaviourNature
-
12월20일
Marine biology: Acidified oceans may corrode shark scalesScientific Reports
-
12월19일
Anthropology: The final stand of Homo erectusNature
-
12월17일
Energy: Health and financial impacts of time-of-use energy rates raise equity concernsNature Energy
